| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JVH.12088 |
| P698 | PubMed publication ID | 23910650 |
| P50 | author | Marie-Annick Le Pogam | Q59682745 |
| Fabien Zoulim | Q33116701 | ||
| P2093 | author name string | M Maynard | |
| L Cotte | |||
| P Miailhes | |||
| F Bailly | |||
| P Pradat | |||
| C Brochier | |||
| P Trolliet | |||
| J-B Okon | |||
| P2860 | cites work | Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | Q46217486 |
| Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy | Q46432681 | ||
| Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. | Q46900196 | ||
| European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults | Q50136108 | ||
| Low incidence of renal impairment observed in tenofovir-treated patients. | Q51050331 | ||
| Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. | Q51554456 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine | Q33196165 | ||
| Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients | Q33645750 | ||
| Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B | Q36238754 | ||
| Association of tenofovir exposure with kidney disease risk in HIV infection | Q37077982 | ||
| Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males. | Q37381725 | ||
| Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. | Q37800919 | ||
| Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence | Q37857483 | ||
| Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. | Q42678962 | ||
| Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. | Q43124511 | ||
| Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France | Q43225383 | ||
| Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups | Q43902376 | ||
| Renal lesions in HIV-1-positive patient treated with tenofovir | Q44379167 | ||
| Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir | Q44760656 | ||
| Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial | Q44975155 | ||
| P433 | issue | 9 | |
| P921 | main subject | tenofovir | Q155954 |
| P304 | page(s) | 650-657 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate | |
| P478 | volume | 20 |
| Q38692333 | DNA polymerase inhibitors for treating hepatitis B: a safety evaluation. |
| Q41224775 | Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. |
| Q50003421 | Effect of tenofovir on renal function in patients with chronic hepatitis B. |
| Q41204065 | Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. |
| Q26773224 | Liver transplantation for viral hepatitis in 2015 |
| Q92088853 | Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate |
Search more.